<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00289822</url>
  </required_header>
  <id_info>
    <org_study_id>158/02</org_study_id>
    <nct_id>NCT00289822</nct_id>
  </id_info>
  <brief_title>Cell Therapy for Coronary Heart Disease</brief_title>
  <official_title>Cell Therapy for Coronary Heart Disease: Infusion of Autologous Ex Vivo Cultivated Endothelial Progenitor Cells (EPCs)&quot; and Autologous Bone Marrow Progenitor Cells in Crossover Design for Improvement of Vascularization and Cardiac Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <brief_summary>
    <textblock>
      Impaired contractile function after a heart attack and due to coronary heart disease is a&#xD;
      major cause of &quot;heart failure&quot; limiting quality of life and prognosis, which cannot be&#xD;
      prevented even with optimal standard therapy.&#xD;
&#xD;
      The aim of the current trial is to investigate whether infusion of progenitor cells into the&#xD;
      coronary artery supplying the most dyskinetic left ventricular area may improve left&#xD;
      ventricular contractile function, compared to no cell infusion in the control group, in&#xD;
      patients with old (&gt;= 3 months) myocardial infarction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  The study is an open-label, controlled, randomized single-center trial.&#xD;
&#xD;
        -  Patients post myocardial infarction (&gt;= 3 months) with a patent infarct-related artery&#xD;
           are included.&#xD;
&#xD;
        -  Bone marrow-derived progenitor cells are aspirated under local anaesthesia, and after&#xD;
           cell processing, are infused into the patent infarct-related artery during stop flow&#xD;
           within the same day. Blood-derived progenitor cells are isolated out of 250ml peripheral&#xD;
           venous blood, and after cell processing and 3 days culture, are infused into the patent&#xD;
           infarct-related artery during stop flow. In addition, left ventricular angiography is&#xD;
           performed. In the control group coronary angiography and left ventricular angiography&#xD;
           without any intracoronary infusion are performed.&#xD;
&#xD;
        -  After 3 months, left ventricular angiography is repeated, and patients of the control&#xD;
           group cross-over to active treatment with progenitor cells, whereas patients initially&#xD;
           treated with progenitor cells cross-over to the alternate cell type.&#xD;
&#xD;
        -  The primary endpoint is the change in quantitative global left ventricular ejection&#xD;
           fraction in LV angiography between the groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>January 2002</start_date>
  <completion_date>January 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in global left ventricular function (measured by quantitative left ventricular angiography)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative parameters of regional left ventricular function of the target area</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in left ventricular volumes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional status as assessed by NYHA classification</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>event-free survival after 4 months follow-up</measure>
  </secondary_outcome>
  <enrollment>75</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intracoronary infusion of progenitor cells</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 to 80&#xD;
&#xD;
          -  Patients post-myocardial infarction (&gt; 3 months old) or with diffuse ischemic CHD&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Existing neoplastic disease or signs of tumor recurrence within the last 5 years&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Active internal bleeding&#xD;
&#xD;
          -  Stroke within the past 2 years&#xD;
&#xD;
          -  Surgery or trauma within the past two months&#xD;
&#xD;
          -  Uncontrolled hypertension over 160/100&#xD;
&#xD;
          -  Arteriovenous malformations or aneurysms&#xD;
&#xD;
          -  HIV infection&#xD;
&#xD;
          -  Signs of significant kidney or liver failure (creatinine &gt; 2.0 mg/dL, GOT &gt; 2 x upper&#xD;
             standard value)&#xD;
&#xD;
          -  Thrombopenia (&lt; 100,000)&#xD;
&#xD;
          -  Anemia (hemoglobin &lt; 8.5 g/dL)&#xD;
&#xD;
          -  Mental retardation&#xD;
&#xD;
          -  Participation in another clinical study&#xD;
&#xD;
          -  Women of childbearing age&#xD;
&#xD;
          -  Chronic inflammatory disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas M Zeiher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>J. W. Goethe University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Volker Schaechinger, MD</last_name>
    <role>Study Director</role>
    <affiliation>J. W. Goethe University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>J. W. Goethe University Hospitals</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Assmus B, Honold J, Sch√§chinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006 Sep 21;355(12):1222-32.</citation>
    <PMID>16990385</PMID>
  </results_reference>
  <verification_date>February 2006</verification_date>
  <study_first_submitted>February 8, 2006</study_first_submitted>
  <study_first_submitted_qc>February 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2006</study_first_posted>
  <last_update_submitted>November 29, 2006</last_update_submitted>
  <last_update_submitted_qc>November 29, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2006</last_update_posted>
  <keyword>chronic heart failure</keyword>
  <keyword>myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

